RBFOX2 suppresses NETosis and glioma growth via 5hmC-dependent PDGFB decay

Xi Chen1, Weiwei Dai1, Hanlin Wang2

  • 1Department of Pharmacology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China; Department of Microbiology, Key Laboratory of Medical Molecular Virology (Ministry of Education/ National Health Commission/ Chinese Academy of Medical Sciences), Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China; Nanhu Laboratory, Jiaxing, Zhejiang Province 314002, China.

Cell Reports
|June 12, 2026
PubMed

Insights

The RNA-binding protein RBFOX2 acts as a tumor suppressor in glioma by inhibiting cell growth and NETosis. Reduced RBFOX2 levels correlate with poor patient survival, highlighting its therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Neutrophil extracellular traps (NETs) play a role in tumor progression, but the mechanisms controlling their induction in cancer are not fully understood.
  • Identifying regulators of NETosis in the tumor microenvironment is crucial for developing novel cancer therapies.

Purpose of the Study:

  • To identify molecular mechanisms regulating NETosis in glioma.
  • To investigate the role of the RNA-binding protein RBFOX2 in glioma progression and NETosis.

Main Methods:

  • Analysis of RBFOX2 expression in glioma patient data.
  • Investigating the interaction of RBFOX2 with PDGFB mRNA and its effect on mRNA decay.
  • Assessing the impact of RBFOX2 on AKT-SP1 signaling and CSF3 transcription.
  • Evaluating NET formation in vivo using PAD4-/- mice and CSF3 neutralization.

Main Results:

  • RBFOX2 expression is significantly reduced in glioma and inversely correlates with patient survival.
  • RBFOX2 binds to 5-hydroxymethylcytidine-modified PDGFB mRNA, promoting its decay.
  • RBFOX2 represses CSF3 transcription, thereby limiting neutrophil-mediated NET formation.
  • RBFOX2 restrains glioma cell proliferation and NETosis, acting as a tumor suppressor.

Conclusions:

  • RBFOX2 functions as a tumor suppressor in glioma by controlling NETosis through a 5hmC-dependent post-transcriptional mechanism.
  • RBFOX2 represents a potential biomarker and therapeutic target for glioma.
  • This study establishes a link between RNA-binding proteins, RNA modification, and immune regulation in cancer evolution.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...